Yoav Charpak‐Amikam

1.1k total citations · 1 hit paper
13 papers, 782 citations indexed

About

Yoav Charpak‐Amikam is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yoav Charpak‐Amikam has authored 13 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Yoav Charpak‐Amikam's work include Immune Cell Function and Interaction (9 papers), Fungal Infections and Studies (3 papers) and CAR-T cell therapy research (2 papers). Yoav Charpak‐Amikam is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Fungal Infections and Studies (3 papers) and CAR-T cell therapy research (2 papers). Yoav Charpak‐Amikam collaborates with scholars based in Israel, United States and Germany. Yoav Charpak‐Amikam's co-authors include Shany Doron, Rotem Sorek, Tamara Goldfarb, Gal Ofir, Eyal Weinstock, Ofir Cohen, Hila Sberro, Shaked Afik, Ofer Mandelboim and Batya Isaacson and has published in prestigious journals such as Nature Communications, The EMBO Journal and Journal of Virology.

In The Last Decade

Yoav Charpak‐Amikam

13 papers receiving 769 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BREX is a novel phage resistance system widespread in microbial genomes

2014 360 citations Tamara Goldfarb, Hila Sberro et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoav Charpak‐Amikam Israel	10	382	278	245	141	113	13	782
Siddharth R. Krishnamurthy United States	11	414 1.1×	327 1.2×	179 0.7×	173 1.2×	58 0.5×	12	970
Laurent Bretaudeau France	10	356 0.9×	559 2.0×	287 1.2×	81 0.6×	99 0.9×	11	998
Dragana Nešić United States	10	261 0.7×	94 0.3×	336 1.4×	75 0.5×	74 0.7×	14	754
Karen Mungall Canada	11	256 0.7×	266 1.0×	44 0.2×	128 0.9×	72 0.6×	20	680
Laura Cliffe United States	13	344 0.9×	154 0.6×	208 0.8×	220 1.6×	37 0.3×	15	934
Lina Guerra Sweden	8	286 0.7×	112 0.4×	87 0.4×	46 0.3×	87 0.8×	8	535
Ximena Cortes-Bratti Sweden	8	267 0.7×	216 0.8×	117 0.5×	51 0.4×	38 0.3×	8	675
Masayuki Imajoh Japan	14	123 0.3×	85 0.3×	243 1.0×	68 0.5×	222 2.0×	43	597
Tobias Paprotka Germany	16	458 1.2×	75 0.3×	154 0.6×	132 0.9×	134 1.2×	20	1.1k
Alex Pelletier Canada	12	273 0.7×	102 0.4×	96 0.4×	229 1.6×	111 1.0×	18	702

Countries citing papers authored by Yoav Charpak‐Amikam

Since Specialization

Citations

This map shows the geographic impact of Yoav Charpak‐Amikam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Charpak‐Amikam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Charpak‐Amikam more than expected).

Fields of papers citing papers by Yoav Charpak‐Amikam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Charpak‐Amikam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Charpak‐Amikam. The network helps show where Yoav Charpak‐Amikam may publish in the future.

Co-authorship network of co-authors of Yoav Charpak‐Amikam

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Charpak‐Amikam. A scholar is included among the top collaborators of Yoav Charpak‐Amikam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Charpak‐Amikam. Yoav Charpak‐Amikam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Charpak‐Amikam, Yoav, Batya Isaacson, Ronen Ben‐Ami, et al.. (2024). The activating receptor NKG2D is an anti-fungal pattern recognition receptor. Nature Communications. 15(1). 8664–8664. 2 indexed citations

Kahlon, Shira, Batya Isaacson, Moriya Gamliel, et al.. (2024). Pregnancy trained decidual NK cells protect pregnancies from harmful Fusobacterium nucleatum infection. PLoS Pathogens. 20(1). e1011923–e1011923. 4 indexed citations

Charpak‐Amikam, Yoav, Batya Isaacson, Tal Levinson, et al.. (2022). Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT. Nature Communications. 13(1). 2463–2463. 18 indexed citations

Isaacson, Batya, Orit Berhani, Yoav Charpak‐Amikam, et al.. (2020). Altered NKp46 Recognition and Elimination of Influenza B Viruses. Viruses. 13(1). 34–34. 7 indexed citations

Reches, Adi, Natan Stein, Batya Isaacson, et al.. (2020). Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. Journal for ImmunoTherapy of Cancer. 8(1). e000266–e000266. 90 indexed citations

Obiedat, Akram, Yoav Charpak‐Amikam, Julie Tai-Schmiedel, et al.. (2019). The integrated stress response promotes B7H6 expression. Journal of Molecular Medicine. 98(1). 135–148. 24 indexed citations

Stein, Natan, Orit Berhani, Dominik Schmiedel, et al.. (2019). IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer Cells. iScience. 11. 466–473. 47 indexed citations

Charpak‐Amikam, Yoav, Einat Seidel, Esther Oiknine‐Djian, et al.. (2017). Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20. Scientific Reports. 7(1). 8661–8661. 39 indexed citations

Bar‐On, Yotam, Yoav Charpak‐Amikam, Ariella Glasner, et al.. (2017). NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. Journal of Virology. 91(19). 16 indexed citations

10.

Enk, Jonatan, Assi Levi, Yiska Weisblum, et al.. (2016). HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion. Cell Reports. 17(4). 949–956. 33 indexed citations

11.

Vitenshtein, Alon, Yoav Charpak‐Amikam, Rachel Yamin, et al.. (2016). NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. Cell Host & Microbe. 20(4). 527–534. 70 indexed citations

12.

Goldfarb, Tamara, Hila Sberro, Eyal Weinstock, et al.. (2014). BREX is a novel phage resistance system widespread in microbial genomes. The EMBO Journal. 34(2). 169–183. 360 indexed citations breakdown →

13.

Yona, Avihu H., Zohar Bloom‐Ackermann, Idan Frumkin, et al.. (2013). tRNA genes rapidly change in evolution to meet novel translational demands. eLife. 2. e01339–e01339. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact